Lates News

Olema Pharmaceuticals (OLMA.US) reported revenue of 0 US dollars for Q3 2025, unchanged from the previous quarter. Earnings per share were -0.49 US dollars, improved from -0.60 US dollars, but below the expected value of -0.44 US dollars.